美国社区医院带状疱疹住院趋势:2001-2015年
本研究利用美国全国住院样本出院数据,分析2001-2015年带状疱疹住院率趋势,并评估2007年水痘疫苗加强剂推荐和2008年带状疱疹疫苗推荐的影响。结果显示,后疫苗政策时代带状疱疹住院率较前政策时代每10万人减少1.9例(2015年比预期少6200例住院),其中≤14岁儿童和≥60岁成人住院率下降,50-59岁成人略升。
要点
- 2007年水痘疫苗加强剂推荐后,≤14岁儿童带状疱疹住院率下降。
- 2008年带状疱疹疫苗推荐后,≥60岁成人住院率下降,尽管接种覆盖率<31%。
- 50-59岁成人带状疱疹住院率略有上升(+0.7/10万)。
核心结论
- 带状疱疹住院率在疫苗政策实施后总体下降,儿童和≥60岁成人受益明显。
研究设计与样本
- 基于美国全国住院样本(Nationwide Inpatient Sample)2001-2015年出院数据的趋势分析,比较疫苗政策前(2001-2005)和后(2012-2015)时期的年均住院率。
主要发现
- 后疫苗政策时期带状疱疹住院率较前时期每10万人减少1.9例,2015年比预期少6200例住院。
- 年龄别住院率差异:0-3岁每10万人减少0.4例(少50例),4-6岁减少0.6例(少50例),7-14岁减少1.3例(少400例)。
- 50-59岁每10万人增加0.7例(多300例),60-69岁减少2.5例(少900例),70-79岁减少10.2例(少2000例),80岁以上减少29.9例(少3600例)。
临床怎么用
- 维持水痘疫苗两剂次接种和≥60岁人群带状疱疹疫苗接种,以降低相关住院负担。
局限性
- 研究为观察性趋势分析,无法直接证明因果关系;疫苗覆盖率低于31%可能影响效果评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In 2007, based on decisions by the U.S. Advisory Committee on Immunization Practices, the CDC recommended a booster dose at 4-6 years in the varicella vaccine schedule. In 2008, a herpes zoster vaccine was recommended for use in persons age ≥60 years. The purpose of this study was to examine trends in herpes zoster hospitalization rates and assess the impact of both policy recommendations using U.S. hospital discharge data. METHODS: Nationwide Inpatient Sample discharge data from 2001 to 2015 were used to identify primary or secondary herpes zoster diagnoses. Trends in annual total and age-specific herpes zoster hospitalization rates and average length of stay were examined. Average annual rates for the pre (2001-2005) and post (2012-2015)-zoster vaccine policy eras were compared. Absolute change in herpes zoster hospitalizations were calculated. RESULTS: The rate difference of U.S. herpes zoster hospitalizations in the post vs. pre-zoster vaccine policy era was -1.9 per 100,000 population (6,200 fewer hospitalizations in 2015 than expected). Key age group rate differences: 0-3 years (-0.4 per 100,000; 50 fewer), 4-6 years (-0.6 per 100,000; 50 fewer), 7-14 years (-1.3 per 100,000; 400 fewer), 50-59 years (0.7 per 100,000; 300 more), 60-69 years (-2.5 per 100,000; 900 fewer), 70-79 years (-10.2 per 100,000; 2,000 fewer), 80+ years (-29.9 per 100,000; 3,600 fewer). CONCLUSIONS: Reduction of wild-type varicella due to the 2-dose varicella vaccination recommendation may have impacted declining herpes zoster hospitalization rates among children ≤14 years. The 2008 herpes zoster vaccine may have impacted declining herpes zoster hospitalization rates for adults age ≥60 years despite vaccination coverage <31% by 2015.
引用
- Pham MA, Bednarczyk RA, Becker ER, et al. Trends in U.S. Community hospitalizations due to herpes zoster: 2001-2015. Vaccine. 2019. PMID: 30616954. doi:10.1016/j.vaccine.2018.12.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。